Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ZFGN

Zafgen (ZFGN) Stock Price, News & Analysis

Zafgen logo

About Zafgen Stock (NASDAQ:ZFGN)

Advanced Chart

Key Stats

Today's Range
$3.34
$3.48
50-Day Range
$0.99
$25.06
52-Week Range
$0.62
$2.76
Volume
687,184 shs
Average Volume
360,199 shs
Market Capitalization
$126.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZFGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zafgen and its competitors with MarketBeat's FREE daily newsletter.

ZFGN Stock News Headlines

Tokyo Steel Manufacturing Co Ltd 5423
Think you missed gold’s boom? Think again
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days.
Food and drink in a castle
LRMR Larimar Therapeutics, Inc.
Form 424B5 Larimar Therapeutics, - StreetInsider.com
See More Headlines

ZFGN Stock Analysis - Frequently Asked Questions

Zafgen Inc (NASDAQ:ZFGN) issued its quarterly earnings results on Thursday, March, 5th. The biopharmaceutical company reported ($0.19) earnings per share for the quarter, hitting the consensus estimate of ($0.19).

Based on aggregate information from My MarketBeat watchlists, some other companies that Zafgen investors own include Xtrackers California Municipal Bond ETF (CA), Bristol Myers Squibb (BMY), Endologix (ELGX), Energy Transfer (ET), BlackRock (BLK), TG Therapeutics (TGTX) and SCYNEXIS (SCYX).

Company Calendar

Last Earnings
3/05/2020
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ZFGN
CIK
1374690
Fax
N/A
Employees
38
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$45.41 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-51.34%
Return on Assets
-34.55%

Debt

Debt-to-Equity Ratio
0.26
Current Ratio
6.56
Quick Ratio
6.56

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.35 per share
Price / Book
2.50

Miscellaneous

Outstanding Shares
37,470,000
Free Float
N/A
Market Cap
$126.65 million
Optionable
Not Optionable
Beta
0.27
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:ZFGN) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners